272 related articles for article (PubMed ID: 12021857)
1. D2 or not D2? The gastrectomy question.
Lewis WG; Edwards P; Barry JD; Khan S; Dhariwal D; Hodzovic I; Allison MC; Shute K
Gastric Cancer; 2002; 5(1):29-34. PubMed ID: 12021857
[TBL] [Abstract][Full Text] [Related]
2. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.
Cuschieri A; Weeden S; Fielding J; Bancewicz J; Craven J; Joypaul V; Sydes M; Fayers P
Br J Cancer; 1999 Mar; 79(9-10):1522-30. PubMed ID: 10188901
[TBL] [Abstract][Full Text] [Related]
3. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
[TBL] [Abstract][Full Text] [Related]
4. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.
Cuschieri A; Fayers P; Fielding J; Craven J; Bancewicz J; Joypaul V; Cook P
Lancet; 1996 Apr; 347(9007):995-9. PubMed ID: 8606613
[TBL] [Abstract][Full Text] [Related]
5. Western body mass indices need not compromise outcomes after modified D2 gastrectomy for carcinoma.
Barry JD; Blackshaw GR; Edwards P; Lewis WG; Murphy P; Hodzovic I; Thompson IW; Allison MC
Gastric Cancer; 2003; 6(2):80-5. PubMed ID: 12861398
[TBL] [Abstract][Full Text] [Related]
6. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
7. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.
Degiuli M; Sasako M; Calgaro M; Garino M; Rebecchi F; Mineccia M; Scaglione D; Andreone D; Ponti A; Calvo F;
Eur J Surg Oncol; 2004 Apr; 30(3):303-8. PubMed ID: 15028313
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients.
Schmid A; Thybusch A; Kremer B; Henne-Bruns D
Hepatogastroenterology; 2000; 47(32):579-85. PubMed ID: 10791243
[TBL] [Abstract][Full Text] [Related]
9. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
[TBL] [Abstract][Full Text] [Related]
11. [Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy].
Ruiz E; Sanchez J; Celis J; Payet E; Berrospi F; Chavez I; Young F
Rev Gastroenterol Peru; 2009; 29(2):124-31. PubMed ID: 19609327
[TBL] [Abstract][Full Text] [Related]
12. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the operative outcomes of D1 and D2 gastrectomy performed at a single Western center with multiple surgeons: a retrospective analysis with propensity score matching.
Lam S; Tan E; Menezes A; Martin D; Gallagher J; Storey D; Sandroussi C
World J Surg Oncol; 2018 Jul; 16(1):136. PubMed ID: 29986713
[TBL] [Abstract][Full Text] [Related]
14. [The prognostic influence of D2 lymphadenectomy with para-aortic lymph nodal dissection for gastric cancer in N3 stage].
Liang YX; Liang H; Ding XW; Wang XN; Zhang L; Wu LL; Liu HG; Jiao XG
Zhonghua Wai Ke Za Zhi; 2013 Dec; 51(12):1071-6. PubMed ID: 24499714
[TBL] [Abstract][Full Text] [Related]
15. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
Roukos DH; Lorenz M; Encke A
Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
[TBL] [Abstract][Full Text] [Related]
16. Lymph node dissection in resectable advanced gastric cancer.
de Steur WO; Dikken JL; Hartgrink HH
Dig Surg; 2013; 30(2):96-103. PubMed ID: 23867585
[TBL] [Abstract][Full Text] [Related]
17. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
18. [A comparative study on the efficacy of spleen-preserving modified D2 radical gastrectomy and D2 radical gastrectomy with splenectomy].
Yao XX; Yan C; Yan M; Li C; Chen J; Xiang M; Chen MM; Zhu ZG; Yin HR; Lin YZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Feb; 13(2):111-4. PubMed ID: 20186620
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer.
Reis E; Kama NA; Doganay M; Atli M; Dolapci M
Hepatogastroenterology; 2002; 49(46):1167-71. PubMed ID: 12143228
[TBL] [Abstract][Full Text] [Related]
20. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer.
Degiuli M; Sasako M; Ponti A; Calvo F
Br J Cancer; 2004 May; 90(9):1727-32. PubMed ID: 15150592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
